Search results for "polyneuropathy"

showing 10 items of 54 documents

Long-Lasting Cranial Nerve III Palsy as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy

2015

We describe a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) in which an adduction deficit and ptosis in the left eye presented several years before the polyneuropathy. A 52-year-old man presented with a 14-year history of unremitting diplopia, adduction deficit, and ptosis in the left eye. At the age of 45 a mild bilateral foot drop and impaired sensation in the four limbs appeared, with these symptoms showing a progressive course. The diagnostic workup included EMG/ENG which demonstrated reduced conduction velocity with bilateral and symmetrical sensory and motor involvement. Cerebrospinal fluid studies revealed a cytoalbuminologic dissociation. A prolonged treatmen…

Diplopiamedicine.medical_specialtyWeaknessbusiness.industrylcsh:Rlcsh:MedicineCase ReportChronic inflammatory demyelinating polyneuropathyGeneral Medicinemedicine.diseaseNerve conduction velocitySurgeryCerebrospinal fluidPtosisSensationmedicineSettore MED/26 - Neurologiamedicine.symptombusinessPolyneuropathypolyneuropathy CIDP cranial nervesCase Reports in Medicine
researchProduct

A Rare Case of Docetaxel-Induced Hydrocephalus Presenting with Gait Disturbances Mimicking and Coexisting with Taxane-Associated Polyneuropathy: The …

2017

Docetaxel constitutes a widely used chemotherapeutic agent as a first-line treatment for several neoplastic diseases. One of the most common side effects induced by this drug is polyneuropathy, which among other symptoms can cause gait disbalance. However, in exceptional cases gait disturbances could be related to docetaxel-induced hydrocephalus, a rare event that up to the present has been overseen throughout the medical literature and should be meticulously differentiated from polyneuropathy, since its clinical features, treatment, and prognosis differ drastically. We present the case of a woman with a progressive gait disturbance that started immediately after having been treated with do…

Gait disturbancesmedicine.medical_specialtyCase ReportDocetaxelVentricular systemlcsh:RC254-28203 medical and health sciences0302 clinical medicineBreast cancerNormal pressure hydrocephalusPolyneuropathyMedicinebusiness.industryGait Disturbancelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseHydrocephalusSurgeryOncologyDocetaxel030220 oncology & carcinogenesisDifferential diagnosisbusinessPolyneuropathy030217 neurology & neurosurgeryHydrocephalusmedicine.drugCase Reports in Oncology
researchProduct

Akutes Nierenversagen auf dem Boden einer Hyperkalzämie und periphere Polyneuropathie – seltene Manifestationen einer Sarkoidose

2000

Hintergrund: Als Systemerkrankung kann die Sarkoidose alle Organsysteme befallen. Neben dem haufigen Befall von Lungen und thorakalen Lymphknoten kommen auch seltene Manifestationen wie Nierenversagen und eine Beteiligung des Nervensystems vor. Fallbericht: Ein 57-jahriger Patient wurde nach einem Urlaub im Suden mit Belastungsdyspnoe und akutem Nierenversagen bei Hyperkalzamie stationar aufgenommen. Der klinische Verdacht einer Sarkoidose als Grunderkrankung mit den ausergewohnlichen extrapulmonalen Manifestationen einer Kalziumnephropathie sowie einer sensiblen Polyneuropathie lies sich bestatigen. Schlusfolgerung: Dieser Fall zeigt, dase eine asymptomatische Sarkoidose durch vermehrte UV…

Gynecologymedicine.medical_specialtybusiness.industryPeripheral polyneuropathymedicineGeneral MedicineSarcoidosismedicine.diseasebusinessSurgeryMedizinische Klinik
researchProduct

Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: A single-center experience

2010

Liver transplantation (LT) is the only curative option for patients with familial amyloid polyneuropathy (FAP) at present. Twenty patients with FAP underwent LT between May 1998 and June 2007. Transthyretin mutations included predominantly the Val30Met mutation but also 10 other mutations. Seven patients received a pacemaker prior to LT, and because of impairment of mechanical cardiac function, 4 combined heart-liver transplants were performed, 1 simultaneously and 3 sequentially. The first patient, who underwent simultaneous transplantation, died. Seven patients died after LT, with 5 dying within the first year after transplantation. The causes of death were cardiac complications (4 patien…

Heart transplantationTransplantationmedicine.medical_specialtyHepatologybiologybusiness.industrymedicine.medical_treatmentRestrictive cardiomyopathyLiver transplantationmedicine.diseaseSingle CenterGastroenterologySurgeryTransplantationTransthyretinInternal medicineHeart failuremedicinebiology.proteinSurgerybusinessPolyneuropathyLiver Transplantation
researchProduct

Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study.

2007

International audience; BACKGROUND: Amyotrophic lateral sclerosis (ALS) is defined as a disease of the motor neurones, although several studies indicate involvement of the sensory nervous system. AIM: To evaluate the sensory nerve conduction studies (NCS) in 88 patients with ALS as part of a European multicentre study. METHODS: Seven European clinical neurophysiologists examined consecutive series of ALS patients. The examinations were peer reviewed, and the diagnosis of ALS was confirmed clinically. RESULTS: 20 (22.7%) patients with ALS had sensory NCS abnormalities in at least one nerve. Of those, 11 (12.5% of all patients) obtained an additional peer review diagnosis of electrophysiologi…

MalePathologyNeural Conduction0302 clinical medicineMESH: Aged 80 and overDorsal root ganglionMESH: Neural ConductionAmyotrophic lateral sclerosisMESH: Amyotrophic Lateral SclerosisAged 80 and overMESH: Aged0303 health sciencesMESH: ElectrophysiologyMESH: Middle AgedMESH: Neurons AfferentMiddle AgedElectrophysiologyEuropePsychiatry and Mental healthmedicine.anatomical_structureMESH: Sensation DisordersSensation DisordersFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]PolyneuropathySensory nerveAdultmedicine.medical_specialtyNeuromuscular diseaseShort ReportSensory systemCentral nervous system disease03 medical and health sciencesmedicineHumans[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Neurons AfferentAged030304 developmental biologyMESH: Humansbusiness.industryAmyotrophic Lateral SclerosisMESH: Adultmedicine.diseaseMESH: MaleSurgeryNeurology (clinical)MESH: EuropebusinessMotor neurone diseaseMESH: Female030217 neurology & neurosurgery
researchProduct

Complexity of the Hereditary Motor and Sensory Neuropathies

2015

Early-onset hereditary motor and sensory neuropathies are rare diseases representing a broad clinical and genetic spectrum. Without a notable familial history, the clinical diagnosis is complicated because acquired causes of peripheral neuropathy, such as inflammatory neuropathies, neuropathies with toxic causes, and nutritional deficiencies, must be considered. We examined the clinical, electrophysiological, and pathologic manifestations of a boy with an initial diagnosis of chronic inflammatory demyelinating polyneuropathy. The progression of the disease despite treatment led to a suspicion of hereditary motor and sensory neuropathy. Genetic testing revealed the presence of the MPZ p.D90…

MalePathologymedicine.medical_specialtyChronic inflammatory demyelinating polyneuropathySensory systemDiseaseBioinformaticsSural NervemedicineHumansGenetic testingmedicine.diagnostic_testbusiness.industrymedicine.diseasePhenotypePeripheral neuropathyChild PreschoolClinical diagnosisMutationPediatrics Perinatology and Child HealthMutation (genetic algorithm)Disease ProgressionNeurology (clinical)Hereditary Sensory and Motor NeuropathybusinessHereditary motor and sensory neuropathyMyelin P0 ProteinHeLa CellsJournal of Child Neurology
researchProduct

Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area

2016

Tafamidis is a transthyretin (TTR) stabilizer able to prevent TTR tetramer dissociation. There have been a few encouraging studies on Tafamidis efficacy in early-onset inherited transthyretin amyloidosis (ATTR) due to Val30Met mutation. However, less is known about its efficacy in later disease stages and in non-Val30Met mutations. We performed a multi-center observational study on symptomatic ATTR patients prescribed to receive Tafamidis. We followed up patients according to a standardized protocol including general medical, cardiological and neurological assessments at baseline and every 6 months up to 3 years. Sixty-one (42 males) patients were recruited. Only 28 % of enrolled subjects h…

MaleTafamidisAmyloid polyneuropathyNeurologyCardiomyopathyDisease030204 cardiovascular system & hematologySeverity of Illness IndexTransthyretinchemistry.chemical_compound0302 clinical medicinePrealbuminTafamidiLongitudinal StudiesStage (cooking)Aged 80 and overBenzoxazolesbiologyAmyloidosisMiddle Agedamyloid polyneuropathy; tafamidis; transthyretinPrognosisTafamidisSettore MED/26 - NEUROLOGIATreatment OutcomeItalyNeurologyDisease ProgressionFemaleAmyloid polyneuropathy; Tafamidis; Transthyretin; Neurology (clinical); NeurologyAdultmedicine.medical_specialty03 medical and health sciencesInternal medicineSeverity of illnessmedicineHumansAgedAmyloid Neuropathies Familialbusiness.industrynutritional and metabolic diseasesmedicine.diseaseSurgeryTransthyretinchemistryMutationbiology.proteinNeurology (clinical)business030217 neurology & neurosurgeryFollow-Up StudiesJournal of Neurology
researchProduct

Risk factors for depression and anxiety in painful and painless diabetic polyneuropathy: A multicentre observational cross‐sectional study

2021

BACKGROUND Despite the high prevalence of depression and anxiety in chronic pain conditions, current knowledge concerning emotional distress among painful diabetic polyneuropathy (pDSPN) and other diabetes mellitus (DM) sufferers is limited. METHODS This observational multicentre cohort study employed the Hospital Anxiety and Depression Scale, the Beck Depression Inventory II and the State-Trait Anxiety Inventory to assess symptoms of depression and anxiety in several groups with diabetes, as well as in a control group. The study cohort included 347 pDSPN patients aged 63.4 years (median), 55.9% males; 311 pain-free diabetic polyneuropathy (nDSPN) patients aged 63.7 years, 57.9% males; 50 d…

Malemedicine.medical_specialtyAnxietyHospital Anxiety and Depression ScaleCohort Studies03 medical and health sciences0302 clinical medicineDiabetic NeuropathiesRisk FactorsDiabetes mellitusInternal medicinemedicineHumans030212 general & internal medicineDepression (differential diagnoses)Depressionbusiness.industryBeck Depression InventoryChronic painMiddle Agedmedicine.disease3. Good healthCross-Sectional StudiesAnesthesiology and Pain MedicineDiabetes Mellitus Type 2NeuralgiaAnxietyFemalePain catastrophizingmedicine.symptombusinessPolyneuropathy030217 neurology & neurosurgeryEuropean Journal of Pain
researchProduct

Nerve conduction velocity and circulating immunocomplexes in type 1 diabetic children.

1991

There is evidence from several laboratories of an increased prevalence of circulating immuno-complexes (CIC) in diabetic patients. It has also been suggested that CIC are pathogenetically related to chronic diabetic complications. The aim of this study was to assess peripheral nerve function in children with Type 1 diabetes and to evaluate the relationship between the neurophysiological abnormalities and the possible presence of CIC. The investigation was carried out in 25 Type 1 diabetic patients ranging in age from 7-19 years and in 20 normal controls. Neurophysiological assessment was performed to evaluate motor and sensory conduction velocity on median and tibial nerves. IgG-CIC were de…

Malemedicine.medical_specialtyDiabetic neuropathyAdolescentSensory Receptor CellsNeural ConductionSensory systemAntigen-Antibody ComplexGastroenterologyNerve conduction velocityPathogenesisDiabetic NeuropathiesInternal medicineElectroneuronographymedicineReaction TimeHumansPeripheral NervesChildMotor NeuronsType 1 diabetesbusiness.industryGeneral Medicinemedicine.diseaseEndocrinologyDiabetes Mellitus Type 1NeurologyFemaleNeurology (clinical)ComplicationbusinessPolyneuropathyActa neurologica Scandinavica
researchProduct

Patient Expectations in the Treatment of Painful Diabetic Polyneuropathy: Results from a Non-Interventional Study

2014

Objective Pain control is the main objective when treating patients with painful diabetic peripheral neuropathic pain (DPNP). However, DPNP is associated with further substantial patient burden that often is not appropriately addressed. Our study identified patients' needs and asked patients what they expected from DPNP treatment. Methods Baseline data were collected in a German prospective, non-interventional study in patients with DPNP starting or switching pain medication at the discretion of the investigator. DPNP severity was evaluated using Brief Pain Inventory (BPI) and Clinician/Patient Global Impression-Severity (CGI-S/PGI-S). Primary objective of this study was to evaluate for whi…

Malemedicine.medical_specialtyDiabetic neuropathyPain medicationCohort StudiesDiabetic NeuropathiesDiabetic polyneuropathyActivities of Daily LivingHumansMedicineIn patientProspective StudiesMobility LimitationBrief Pain InventoryAgedbusiness.industryPatient PreferenceGeneral MedicineMiddle Agedmedicine.diseasehumanitiesConfidence intervalAnesthesiology and Pain MedicineMoodPatient SatisfactionNon interventionalQuality of LifePhysical therapyFemaleNeurology (clinical)businessAttitude to HealthNeeds AssessmentPain Medicine
researchProduct